BioSyent Inc. (BIOYF)
OTCMKTS · Delayed Price · Currency is USD
8.82
+0.04 (0.46%)
Dec 8, 2025, 9:30 AM EST
BioSyent Market Cap
BioSyent has a market cap or net worth of $99.56 million as of December 9, 2025. Its market cap has increased by 7.13% in one year.
Market Cap
99.56M
Enterprise Value
83.31M
Revenue
30.28M
Ranking
n/a
PE Ratio
16.06
Stock Price
$8.82
Market Cap Chart
Since April 24, 1997, BioSyent's market cap has increased from 9.48M to 99.56M, an increase of 950.03%. That is a compound annual growth rate of 8.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 98.95M | 11.49% |
| Dec 31, 2024 | 88.75M | 8.08% |
| Dec 29, 2023 | 82.11M | 31.23% |
| Dec 30, 2022 | 62.57M | -23.01% |
| Dec 30, 2021 | 81.27M | 2.23% |
| Dec 31, 2020 | 79.49M | 24.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 561.91M |
| Glass House Brands | 513.14M |
| CytoDyn | 403.93M |
| American Oncology Network | 365.47M |
| Northwest Biotherapeutics | 363.73M |
| Silence Therapeutics | 328.75M |
| Nika Pharmaceuticals | 259.91M |